Contents
Download PDF
pdf Download XML
408 Views
121 Downloads
Share this article
Research Article | Volume 13 Issue:2 (, 2023) | Pages 254 - 257
Mycobacterium w, New Hope to Sepsis Patients: Initial Experience from Single center
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
April 20, 2023
Abstract

Background: Mycobacterium wis an immunomodulatorthat evokes antigen-specific cell-mediated immunity and its use has been evaluated in patients with sepsis, where it resulted in improved outcome.  Methods: We collected data in ten adult patientswith suspected gram-negative sepsis admitted inthe intensive care unit. Injection Mw 0.3 ml was administered intradermal per day for three consecutive days alongwith continuation of standard care. Results: We observed clinical improvement and a significant decrease in TLC and SOFA Score on day 7 after Mw administration. Also, Mw was not associated with any local or systemic adverse effects. Conclusion: The use of Mw was safe and effective in patients with sepsis, though larger randomized trials are required to establish its role.

Keywords
Recommended Articles
Research Article
Electrical and haemodynamic changes in heart of patient with chronic obstructive lung diseases
...
Published: 07/10/2025
Download PDF
Research Article
Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study
Published: 30/06/2019
Download PDF
Research Article
Screening of methicillin-resistant Staphylococcus aureus (MRSA) in patients and health care workers and its susceptibility to mupirocin and vancomycin in a tertiary care teaching hospital of West Bengal
...
Published: 28/05/2025
Download PDF
Research Article
Transport Risk Index of Physiologic Stability as a Predictor of Short-Term Outcomes in Critically Ill Transported Neonates: A Prospective Observational Study
...
Published: 30/09/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.